Behcet disease: Do individual symptomatology or certain drug intake reflect the severity of sensory neural hearing loss?

Background: Behcet disease is a relapsing, chronic, systemic inflammatory illness characterized by mucocutaneous, articular, neurological, urogenital, vascular, intestinal, and pulmonary symptoms in addition to recurrent aphthous stomatitis, genital ulcerations, and ophthalmic disease. Objectives: Assessing effect of disease symptomatology, drugs used on sensorineural hearing loss severity. Methods: In this study, sixty adult Behcet disease patients participated. All underwent a comprehensive medical history, a basic audiological assessment, a Behcet disease current activity form, and a tinnitus handicap inventory scale. Results: 60% of the participants, had sensorineural hearing loss; over half (55.6%) had mild sensorineural hearing loss, there is no statistically significant correlation between the duration, the Behcet disease current activity form score, the tinnitus handicap inventory scale, vascular symptoms, and sensorineural hearing loss. Conclusions: prevalence of sensorineural hearing loss is 60%. Auditory manifestations and HB level are independent factors for SNHL, no relation between disease manifestation, duration, disease activity, drugs and severity of hearing loss, no relation between level of platelets, HB, TLC, CRP, ESR and severity of hearing loss.